Healthplus.ai has raised €2.3 million to enhance its AI platform aimed at reducing postoperative infections and to support its international expansion.
Information on the Target
Healthplus.ai is a Netherlands-based HealthTech company that has successfully secured €2.3 million in growth capital. This funding will accelerate the development and international rollout of their AI platform, which is designed to predict the risk of postoperative infections. By correlating these predictions with treatment actions, Healthplus.ai aims to significantly reduce complications and recovery times associated with surgical procedures.
The company's innovative solution leverages artificial intelligence to provide healthcare professionals with insights that enhance patient outcomes, ultimately improving overall healthcare efficiency. This combination of technology and health care has the potential to lead to transformative changes in post-surgery protocols.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The HealthTech industry in the Netherlands has been experiencing considerable growth in recent years. With a strong emphasis on innovation and digital health solutions, the country is recognized as a global leader
Similar Deals
819 Capital Partners → RiverD International
2026
Holland Capital → Gullimex
2025
TFH Holland → Salders
2024
Health Investment Partners → Dytter
2023
Craft Capital → Cleanroom Combination Group
2023
Social IV → TheSocialMedwork
2023
Elevating Capital
invested in
Healthplus.ai
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $2M